This company is not actively trading or the ticker does belong to another company in our database now.
Insider Roster
- David Samuel Tweardy, 2025-08-06
- Jr L Wallace Hall, 2025-05-02
- Shaheen Wirk, 2025-05-02
- Leroy Jeffrey Larson, Svp, Research & Development, 2025-04-21
- Paul Stephen O'brien, Principal Accounting Officer, 2025-04-21
- Yixin Chen, Vp, Chem, Mfg and Ctrls, 2025-04-21
- Daniel Avi Conn, Chief Financial Officer, 2025-04-21
- M.d. Saewook John Kauh, Chief Medical Officer, 2025-04-21
- Nizamudin Imran Alibhai, Chief Executive Officer, 2025-04-21
- Ph.d. Susan Shiff, 2025-04-21
- S Michael Wyzga, 2025-04-21
- Cynthia Smith, 2025-04-21
- Sujal Shah, 2025-04-21
- Christopher Posner, President and Ceo, 2025-03-04
- Scott Terrillion, Sec'y; Chief Compliance & G.c., 2025-03-04
- M Helen Boudreau, 2024-06-06
- Lisa Moltke Von, 2024-06-06
- L. Jeffrey Ives, 2024-06-06
- Martin Vogelbaum, 2024-06-06
- Joana Goncalves, Chief Medical Officer, 2024-04-09
- D Ryan Maynard, Chief Financial Officer, 2024-02-12
- Ph.d. Frederique Menzaghi, Chief Scientific Off,Svp-R&D, 2024-02-05
- Ltd Csl, 2023-07-25
- Jr M Harrison Bains, Director, 2023-06-05
- Richard Makara, Vp, Head Of Accting;Controller, 2022-06-16
- Charles Thomas Reilly, Chief Financial Officer, 2022-03-04
- Ltd. Pharma Renal Care Medical Fresenius Vifor, Large Shareholder, 2021-10-21
- Ltd (International) Vifor, Large Shareholder, 2021-10-21
- Ltd. Pharma Vifor, Large Shareholder, 2021-10-21
- T Derek Chalmers, President & Ceo, 2021-09-09
- Mani Mohindru, Cfo & Chief Strategy Officer, 2019-12-05
- William Joseph Stauffer, Chief Medical Officer, 2018-10-19
- Josef Schoell, Chief Financial Officer, 2017-07-28
- Dean Slagel, Director, 2017-07-03
- Rho Capital Partners Llc, Large Shareholder, 2017-04-03
- Joshua Ruch, Large Shareholder, 2017-04-03
- Habib Kairouz, Large Shareholder, 2017-04-03
- Mark Leschly, Large Shareholder, 2017-04-03
- Rho Ventures Vi Lp, Large Shareholder, 2017-04-03
- Rmv Vi, L.l.c., Large Shareholder, 2017-04-03
- E Michael Lewis, Chief Scientific Advisor, 2017-03-10
- Robert Medve, Chief Medical Officer, 2014-06-19
- Ph.d. Charles Moller, Director, 2014-02-05
- Farah Champsi, Large Shareholder, 2014-02-05
- Alta Biopharma Partners Iii Gmbh & Co Beteiligungs Kg, Large Shareholder, 2014-02-05
- Alta Embarcadero Biopharma Partners Iii Llc, Large Shareholder, 2014-02-05
- Alta Biopharma Management Iii Llc, Large Shareholder, 2014-02-05
- Alta Biopharma Partners Iii Lp, Large Shareholder, 2014-02-05
- Edward Hurwitz, Large Shareholder, Director, 2014-02-05
- Edward Penhoet, Large Shareholder, 2014-02-05
Show All Insiders (50) Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
| 1. | | 704,118 | $16,427,073 | | 0.28% |
| 2. | | 176,030 | $3,631,499 | | 0.24% |
| 3. | | 43,225 | $1,008,439 | | 0% |
| 4. | | 31,234 | $728,689 | | 0% |
| 5. | | 24,980 | $582,784 | | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
| Large Shareholder | $18.19 | 500,000 | $9,095,700.00 | 3,568,057 | 2017-03-31 | Filing |
| Director | $4.93 | 247,727 | $1,221,368.43 | 3,068,057 | 2016-03-17 | Filing |
| Director | $4.78 | 152,273 | $727,834.49 | 2,820,330 | 2016-03-16 | Filing |
| Large Shareholder | $4.93 | 247,727 | $1,221,368.43 | 3,068,057 | 2016-03-17 | Filing |
| Large Shareholder | $4.78 | 152,273 | $727,834.49 | 2,820,330 | 2016-03-16 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
| | $4.75 | 583 | $2,769.25 | 13,109 | 2025-02-28 | Filing |
| | $4.76 | 163 | $775.88 | 7,190 | 2025-02-28 | Filing |
| | $4.72 | 372 | $1,755.84 | 13,692 | 2025-02-04 | Filing |
| | $0.29 | 3,668 | $1,063.72 | 168,768 | 2024-11-04 | Filing |
| | $0.35 | 4,149 | $1,452.15 | 172,436 | 2024-08-01 | Filing |
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
| 1. | | 3 | $117 | 0% |
| 2. | | 2 | $86 | 0% |
| 3. | | 0 | $0 | 0% |